Related Experiment Video

Updated: Aug 12, 2026

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Resistant Haemophilus influenzae in community-acquired respiratory tract infections: a role for cefixime

Jan Verhoef1, A Gillissen

  • 1Eijkman-Winkler Institute of Medical and Clinical Microbiology, University Medical Center, Utrecht, Netherlands. j.verhoef@lab.azu.nl

International Journal of Antimicrobial Agents
|June 7, 2003
PubMed

Insights

Haemophilus influenzae resistance is increasing globally due to beta-lactamases and altered PBP targets. Third-generation cephalosporins show promise for treating respiratory tract infections caused by this resistant bacteria.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Increasing global resistance of *Haemophilus influenzae* over the past 30 years is a significant public health concern.
  • Mechanisms of resistance include beta-lactamase production and alterations in penicillin-binding protein (PBP) targets.
  • This resistance necessitates novel therapeutic strategies for managing upper and lower respiratory tract infections (URTIs and LRTIs).

Purpose of the Study:

  • To review the role of *H. influenzae* in respiratory tract infections (RTIs).
  • To examine changing trends in epidemiological surveillance of *H. influenzae* resistance.
  • To discuss therapeutic implications based on clinical trial data, focusing on effective antimicrobial agents.

Main Methods:

  • Review of published literature and clinical trials.
  • Analysis of epidemiological surveillance data on *H. influenzae* resistance patterns.
  • Evaluation of in vitro antimicrobial activity and clinical efficacy data.

Main Results:

  • Third-generation cephalosporins demonstrate excellent in vitro activity against both beta-lactamase-positive and -negative *H. influenzae* isolates.
  • These agents show proven clinical efficacy across a broad spectrum of RTIs.
  • Surveillance data highlights evolving resistance trends impacting treatment choices.

Conclusions:

  • Third-generation cephalosporins represent a valuable therapeutic option for RTIs caused by *H. influenzae*, including resistant strains.
  • Continued epidemiological surveillance is crucial for guiding effective antimicrobial therapy.
  • Understanding resistance mechanisms is key to developing future treatment strategies.

More Related Videos

Assessing Respiratory Immune Responses to Haemophilus Influenzae06:32

Assessing Respiratory Immune Responses to Haemophilus Influenzae

Published on: June 29, 2021

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Related Concept Videos

Acute Pharyngitis01:30

Acute Pharyngitis

Introduction
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...